[go: up one dir, main page]

UA66772C2 - Спосіб лікування або полегшення ішемії міокарда (варіанти) та препарат прогестерону для використання у вказаній терапії (варіанти) - Google Patents

Спосіб лікування або полегшення ішемії міокарда (варіанти) та препарат прогестерону для використання у вказаній терапії (варіанти)

Info

Publication number
UA66772C2
UA66772C2 UA99052985A UA99052985A UA66772C2 UA 66772 C2 UA66772 C2 UA 66772C2 UA 99052985 A UA99052985 A UA 99052985A UA 99052985 A UA99052985 A UA 99052985A UA 66772 C2 UA66772 C2 UA 66772C2
Authority
UA
Ukraine
Prior art keywords
treating
variants
ischemia
progesterone
incidence
Prior art date
Application number
UA99052985A
Other languages
English (en)
Russian (ru)
Inventor
Говард Л. Лівайн
Уільям Дж. Бологна
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA66772(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of UA66772C2 publication Critical patent/UA66772C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Винахід стосується способу лікування або полегшення ішемії міокарда або частоти кардіоваскулярних порушень шляхом застосування прогестерону. Прогестерон, на відміну від синтетичних прогестинів, показав не зниження, а посилення позитивних ефектів естрогенної терапії при ішемії міокарда у жінок.
UA99052985A 1996-11-04 1997-11-04 Спосіб лікування або полегшення ішемії міокарда (варіанти) та препарат прогестерону для використання у вказаній терапії (варіанти) UA66772C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia
PCT/US1997/020923 WO1998019681A1 (en) 1996-11-04 1997-11-04 Progesterone for treating or reducing ischemia

Publications (1)

Publication Number Publication Date
UA66772C2 true UA66772C2 (uk) 2004-06-15

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99052985A UA66772C2 (uk) 1996-11-04 1997-11-04 Спосіб лікування або полегшення ішемії міокарда (варіанти) та препарат прогестерону для використання у вказаній терапії (варіанти)

Country Status (26)

Country Link
US (2) US5985861A (uk)
EP (1) EP0956023B1 (uk)
KR (1) KR100434623B1 (uk)
CN (1) CN100341512C (uk)
AR (1) AR009407A1 (uk)
AT (1) ATE321558T1 (uk)
AU (1) AU715740C (uk)
BR (1) BR9710918A (uk)
CA (1) CA2270565C (uk)
DE (1) DE69735598T2 (uk)
DK (1) DK0956023T3 (uk)
ES (1) ES2262196T3 (uk)
GE (1) GEP20022630B (uk)
HU (1) HUP9904045A3 (uk)
IL (1) IL127455A (uk)
LV (1) LV12342B (uk)
MA (1) MA24391A1 (uk)
MY (1) MY121627A (uk)
NO (1) NO324278B1 (uk)
NZ (1) NZ335306A (uk)
PE (1) PE9899A1 (uk)
PT (1) PT956023E (uk)
RO (1) RO120607B1 (uk)
UA (1) UA66772C2 (uk)
WO (1) WO1998019681A1 (uk)
ZA (1) ZA979862B (uk)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7572780B2 (en) 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
EP1620060B1 (en) 2003-04-29 2010-03-24 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102098991B (zh) 2008-02-04 2014-10-22 特卫华妇女健康有限公司 包含孕酮的一体式阴道环以及其制备方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
MX2016013693A (es) 2014-07-29 2017-10-31 Therapeuticsmd Inc Crema transdermica.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
US11787835B2 (en) 2018-09-07 2023-10-17 Trustees Of Dartmouth College C19 scaffolds and steroids and methods of use and manufacture thereof
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
GB202316026D0 (en) * 2023-10-19 2023-12-06 Theramex Hq Uk Ltd Methods of prevention or treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
DE3486448T2 (de) * 1983-11-14 1997-10-09 Columbia Lab Inc Bioadhäsive Mittel
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
RO120607B1 (ro) 2006-05-30
CA2270565C (en) 2007-02-20
MA24391A1 (fr) 1998-07-01
MY121627A (en) 2006-02-28
ES2262196T3 (es) 2006-11-16
KR20000053056A (ko) 2000-08-25
LV12342B (en) 2000-01-20
NO992140D0 (no) 1999-05-03
CN1235549A (zh) 1999-11-17
LV12342A (lv) 1999-09-20
DE69735598D1 (de) 2006-05-18
US5985861A (en) 1999-11-16
US6054447A (en) 2000-04-25
CN100341512C (zh) 2007-10-10
NO324278B1 (no) 2007-09-17
CA2270565A1 (en) 1998-05-14
ATE321558T1 (de) 2006-04-15
HUP9904045A2 (hu) 2000-04-28
HK1020534A1 (en) 2000-05-12
DE69735598T2 (de) 2006-12-28
AU5180198A (en) 1998-05-29
EP0956023A1 (en) 1999-11-17
EP0956023B1 (en) 2006-03-29
PT956023E (pt) 2006-08-31
GEP20022630B (en) 2002-02-25
PE9899A1 (es) 1999-02-08
NZ335306A (en) 2000-12-22
HUP9904045A3 (en) 2000-11-28
AR009407A1 (es) 2000-04-12
AU715740C (en) 2004-04-29
NO992140L (no) 1999-05-04
IL127455A (en) 2005-03-20
DK0956023T3 (da) 2006-08-07
BR9710918A (pt) 2000-01-11
WO1998019681A1 (en) 1998-05-14
IL127455A0 (en) 1999-10-28
KR100434623B1 (ko) 2004-06-05
AU715740B2 (en) 2000-02-10
ZA979862B (en) 1998-05-25

Similar Documents

Publication Publication Date Title
UA66772C2 (uk) Спосіб лікування або полегшення ішемії міокарда (варіанти) та препарат прогестерону для використання у вказаній терапії (варіанти)
TW221027B (uk)
AU5348194A (en) Method of preventing nmda receptor complex-mediated neuronal damage
UA48973C2 (uk) Трансдермальний пластир на основі 17-деацетилноргестимату для попередження овуляції
MY138240A (en) Method of treating androgenic alopecia with 5- alpha reductase inhibitors.
ZA200005413B (en) Cholesterol sulfate compositions for enhancement of stratum corneum function.
AU2002216748A1 (en) Method of treatment of seborrheic dermatitis
TW325996B (en) Anti-atherosclerotic composition containing 17α-dihydroequilin
BG102660A (en) Combined pharmaceutical preparation of lhrh-analogues and antiesterogens for the treatment of gynaecological disorders
TW349000B (en) Fungicidal two-component composition based on R-metalaxyl and usage thereof
MY111718A (en) Deuterated active substances in transdermal application
NZ326345A (en) Composition containing diosgenin
WO1990013643A3 (en) Glycoprotein hormone receptor molecules
EP0910375A4 (en) COMPOSITION BASED ON ENALAPRIL AND LOSARTAN
CA2318125A1 (en) Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
EP0494247A4 (uk)
UA43337C2 (uk) Гормональний засіб для лікування вугрів
MD916G2 (ro) Unguent pentru tratamentul afecţiunilor dentare
RO118794B1 (ro) Metodă de tratament a unor stări dependente de steroizii gonadici
张建民 et al. Electron theory study of the mechanism of hydrogen embrittlement in α-Fe
胡国俊 et al. Antisperm antibody inhibits spermatozoa acrosome reaction (AR) induced by progesterone and affects the free Ca^(2+) changes in spermatozoa
PH30474A (en) Anit-atherosclerotic use of 17 alpha-dihydroequilin
Wehrle How Did the XVIIth Century Perceive the Brittle Fracture of Iron Edict of the King in 1640?
JPS5250447A (en) Lock structure of tightening nut
UA25580C2 (uk) Засіб для лікування алопецій